Evidence map›Paper›PMID 30567709›Full record

ArticleThe Journal of general physiology2019

Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance.

Rebecca E Slater, Joshua G Strom, Mei Methawasin, Martin Liss, Michael Gotthardt, Nancy Sweitzer, Henk L Granzier

Open access · hybridFull text read
In one paragraph

Article in The Journal of general physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Metformin Beyond Glycemic Control: Cardiovascular Protection and Diabetes Prevention.Journal of cardiovascular development and disease · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Novel Drug Targets in Diastolic Heart Disease.International journal of molecular sciences · 2025
    Review
  9. CaBiophysical journal · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Titin: roles in cardiac function and diseases.Frontiers in physiology · 2024
    Review
  19. Immunometabolism at the Heart of Cardiovascular Disease.JACC. Basic to translational science · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rebecca E SlaterDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ.
Joshua G StromDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ.ORCID 0000-0003-1236-1877
Mei MethawasinDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ.ORCID 0000-0002-2509-1936
Martin LissNeuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Michael GotthardtNeuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Nancy SweitzerSarver Heart Center, College of Medicine, University of Arizona, Tucson, AZ.ORCID 0000-0002-8117-6678
Henk L GranzierDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ granzier@email.arizona.edu.ORCID 0000-0002-9516-407X
University of Arizona · USMax Delbrück Center · DE

Funding

Function of Giant Sarcomere Matrix Proteins in MuscleR01HL062881 · NHLBI · WASHINGTON STATE UNIVERSITY · PI GRANZIER, HENK L. · 1999 to 2018
$6.4M
Myofilament-based mechanisms of diastolic dysfunction in HFpEFR01HL118524 · NHLBI · UNIVERSITY OF ARIZONA · PI GRANZIER, HENK L., LEWINTER, MARTIN M · 2014 to 2017
$2.5M
Computational and Mathematical Modeling of Biomedical SystemsT32GM084905 · NIGMS · UNIVERSITY OF ARIZONA · PI SECOMB, TIMOTHY W. · 2009 to 2018
$2.2M
NHLBI NIH HHS R01 HL062881NHLBI NIH HHS R01 HL118524NIGMS NIH HHS T32 GM084905
6 · The paper itself

Abstract

Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome characterized by a preserved ejection fraction but increased diastolic stiffness and abnormalities of filling. Although the prevalence of HFpEF is high and continues to rise, no effective therapies exist; however, the diabetic drug metformin has been associated with improved diastolic function in diabetic patients. Here we determine the therapeutic potential of metformin for improving diastolic function in a mouse model with HFpEF-like symptoms. We combine transverse aortic constriction (TAC) surgery with deoxycorticosterone acetate (DOCA) supplementation to obtain a mouse model with increased diastolic stiffness and exercise intolerance. Echocardiography and pressure-volume analysis reveal that providing metformin to TAC/DOCA mice improves diastolic function in the left ventricular (LV) chamber. Muscle mechanics show that metformin lowers passive stiffness of the LV wall muscle. Concomitant with this improvement in diastolic function, metformin-treated TAC/DOCA mice also demonstrate preserved exercise capacity. No metformin effects are seen in sham operated mice. Extraction experiments on skinned ventricular muscle strips show that the metformin-induced reduction of passive stiffness in TAC/DOCA mice is due to an increase in titin compliance. Using phospho-site-specific antibodies, we assay the phosphorylation of titin's PEVK and N2B spring elements. Metformin-treated mice have unaltered PEVK phosphorylation but increased phosphorylation of PKA sites in the N2B element, a change which has previously been shown to lower titin's stiffness. Consistent with this result, experiments with a mouse model deficient in the N2B element reveal that the beneficial effect of metformin on LV chamber and muscle stiffness requires the presence of the N2B element. We conclude that metformin offers therapeutic benefit during HFpEF by lowering titin-based passive stiffness.

Indexed as

AnimalsDesoxycorticosterone AcetateDiastoleDisease Models, AnimalHeart FailureHeart VentriclesMaleMetforminMiceMice, Inbred C57BLMyocardiumPhosphorylationProtein KinasesStroke VolumeDesoxycorticosterone AcetateMetforminProtein Kinasestitin protein, mouse

Identifiers

PMID30567709
PMCPMC6314384
OpenAlexW2904064446

What Socratic holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.